SMAD4 - Molecular gladiator of the TGF-β signaling is trampled upon by mutational insufficiency in colorectal carcinoma of Kashmiri population: An analysis with relation to KRAS proto-oncogene

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Sameer, A S ^a   Chowdri, Nissar A ^a   Syeed, Nidda ^a   Banday, Mujeeb Z ^b   Shah, Zaffar A ^a   Siddiqi, Mushtaq A ^a  

^a SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF KASHMIR   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; ASPARTIC ACID; CYSTEINE; GLYCINE; HISTIDINE; K RAS PROTEIN; LEUCINE; PESTICIDE; PHENYLALANINE; SERINE; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; KRAS PROTEIN, HUMAN; ONCOPROTEIN; RAS PROTEIN; SMAD4 PROTEIN, HUMAN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; COLORECTAL CARCINOMA; COLORECTAL SURGERY; CONSTIPATION; CONTROLLED STUDY; EXON; FEMALE; GENE CLUSTER; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; INDIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; RECTUM HEMORRHAGE; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR LOCALIZATION; URBAN RURAL DIFFERENCE; ADENOCARCINOMA; AGED; CHI SQUARE DISTRIBUTION; COLORECTAL TUMOR; ETHNOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHENOTYPE; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HUMANS; INDIA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM STAGING; PHENOTYPE; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; SIGNAL TRANSDUCTION; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 77954876811     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-300     Document Type: Article

References (55)

1. Calvert PM, Frucht H. The genetics of CRC. Ann Intern Med 2002, 137:603-612. 12353948.
2. Kemp Z, Thirlwell C, Sieber O, Silver A, Tomlinson I. An update on the genetics of CRC. Hum Mol Gene 2004, 13(2):R177-R185. 10.1093/hmg/ddh247.
3. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL. Genetic alterations during colorectal-tumor development. N Engl J Med 1988, 319:525-532.
4. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in CRC. Cancer Res 1998, 58:5248-5257.
5. Conlin A, Smith G, Carey FA, Wolf CR, Steele RJ. The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma. Gut 2005, 54:1283-1286. 10.1136/gut.2005.066514, 1774675, 15843421.
6. Hsieh JS, Lin SR, Chang MY, Chen FM, Lu CY, Huang TJ, Huang YS, Huang CJ, Wang JY. APC, K-ras, and p53 gene mutations in CRC patients: correlation to clinicopathologic features and postoperative surveillance. Am.Surg 2005, 71:336-343.
7. Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, de Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996, 271:350-353. 10.1126/science.271.5247.350, 8553070.
8. Riggins GJ, Thiagalingam S, Rozenblum E, Weinstein CL, Kern SE, Hamilton SR, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B. Mad-related genes in the human. Nat Genet 1996, 13:347-349. 10.1038/ng0796-347, 8673135.
9. Riggins GJ, Kinzler KW, Vogeistein B, Thiagalingam S. Frequency of smad gene mutations in human cancers. Cancer Res 1997, 57:2578-2580.
10. Saffroy R, Lemoine A, Debuire B. SMAD4 (mothers against decapentaplegic homolog 4 (Drosophila). 2004, Atlas Genet Cytogenet Oncol Haematol., http://AtlasGeneticsOncology.org/Genes/SMAD4ID371.html
11. Attisano L, Wrana JL. Smads as transcriptional co-modulators. Curr Opin Cell Biol 2000, 12:235-243. 10.1016/S0955-0674(99)00081-2, 10712925.
12. Attisano L, Lee-Hoeflich ST. The Smads. Genome Biology 2001, 2:reviews3010.1-30108.
13. Shi Y. Structural insights on Smad function in TGFβ signaling. Bioessays 2001, 23:223-232. 10.1002/1521-1878(200103)23:3<223::AID-BIES1032>3.0.CO;2-U, 11223879.
14. Sameer AS, Chowdhri NA, Abdullah S, Shah ZA, Siddiqi MA. Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: A report. Indian J cancer 2009, 3:219-225.
15. Sameer AS, Rehman S, Pandith AA, Syeed N, Shah ZA, Chowdhri NA, Wani KA, Siddiqi MA. Molecular gate keepers succumb to gene aberrations in colorectal cancer in Kashmiri population, revealing a high incidence area. Saudi J Gastroenterol 2009, 15:244-252. 10.4103/1319-3767.56102, 19794270.
16. Hussain I, ul Rehman S, Afroze D, et al. Mutational spectrum of conserved regions of TP53 and PTEN genes in Kangri cancer (of the skin) in the Kashmiri population. Mutat Res 2009, 676:5-10.
17. Shah A, Jan GM. Pattern of cancer at Srinagar (Kashmir). Indian J Pathol Microbiol 1990, 33:118-23.
18. Murtaza I, Mushtaq D, Margoob MA, Dutt A, Wani NA, Ahmad I, Bhat ML. A study on p53 gene alterations in esophageal squamous cell carcinoma and their correlation to common dietary risk factors among population of the Kashmir valley. World J Gastroenterol 2006, 12:4033-4037.
19. Salam I, Hussain S, Mir MM, Dar NA, Abdullah S, Siddiqi MA, Lone RA, Zargar SA, Sharma S, Hedau S, Basir SB, Bharti AC, Das BA. Aberrant promoter methylation and reduced expression of p16 gene in esophageal squamous cell carcinoma from Kashmir valley: a high-risk area. Mol Cell Biochem 2009, 332:51-58. 10.1007/s11010-009-0173-7, 19513816.
20. Mir MM, Dar NA, Gochhait S, Zargar SA, Ahangar AG, Bamezai RN. p53 Mutation profile of squamous cell carcinomas of the esophagus in Kashmir (India): a high-incidence area. Int J Cancer 2005, 116:62-68. 10.1002/ijc.21002, 15761872.
21. Siddiqi M, Kumar R, Fazili Z, Spiegelhalder B, Preussmann R. Increased exposure to dietary amines and nitrate in a population at high risk of esophageal and gastric cancer in Kashmir (India). Carcinogenesis 1992, 13:1331-5. 10.1093/carcin/13.8.1331, 1499084.
22. Boyle P, Elena M. Epidemiology of colorectal cancer. British Medical Bulletin 2002, 64:1-25. 10.1093/bmb/64.1.1, 12421722.
23. Fearon ER, Cho KR, Nigro JM, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 1990, 247:49-56. 10.1126/science.2294591, 2294591.
24. Elliott RL, Blobe GC. Role of transforming growth factor beta in human cancer. J of Clin Oncol 2005, 23:2078-2093.
25. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor β in human disease. N Engl J Med 2000, 342:1350-1358. 10.1056/NEJM200005043421807, 10793168.
26. Miyaki M, Iijima T, Konishi M, et al. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 1999, 18:3098-3103. 10.1038/sj.onc.1202642, 10340381.
27. Koyama M, Ito M, Nagai H, Emi M, Moriyama Y. Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers: identification of seven novel somatic mutations in tumors from Japanese patients. Mutat Res 1999, 406:71-77.
28. Bierie B, Moses HL. TGF-β and cancer. Cytokine & Growth Factor Reviews 2006, 17:29-40. 16289860, 10.1016/j.cytogfr.2005.09.006.
29. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-β family signaling. Nature 2003, 425:577-584. 10.1038/nature02006, 14534577.
30. Massague J. TGF-β signal transduction. Annu Rev Biochem 1998, 67:753-791. 10.1146/annurev.biochem.67.1.753, 9759503.
31. Yang G, Yang X. Smad4-mediated TGF-β signaling in tumorigenesis. Int J Biol Sci 2010, 6:1-8. 2808050, 20087440.
32. Shi Y. Structural insights on Smad function in TGF-β signaling. Bioessays 2001, 23:223-232. 10.1002/1521-1878(200103)23:3<223::AID-BIES1032>3.0.CO;2-U, 11223879.
33. Schutte M, Hruban RH, Hedrick L, et al. DPC4 gene in various tumor types. Cancer Res 1996, 56:2527-2530.
34. Woodford-Richens KL, Rowan AJ, Poulsom R, et al. Comprehensive analysis of SMAD4 mutations and protein expression in juvenile polyposis: evidence for a distinct genetic pathway and polyp morphology in SMAD4 mutation carriers. Am J Pathol 2001, 159:1293-1300. 1850516, 11583957.
35. Roth S, Johansson M, Loukola A, Peltomaki P, Jarvinen H, Mecklin J-P, Aaltonen LA. Mutation analysis of SMAD2, SMAD3, and SMAD4 genes in hereditary non-polyposis CRC. J. Cell Sci 2003, 11:413-419.
36. Iacobuzio-Donahue CA, Song J, Parmiagiani G, Yeo CJ, Hruban RH, Kern SE. Missense mutations of MADH4: characterization of the mutational hot spot and functional consequences in human tumors. Clin. Cancer Res 2004, 10:1597-1604. 10.1158/1078-0432.CCR-1121-3, 15014009.
37. Zhang B, Halder SK, Kashikar ND, Cho YJ, Datta A, Gorden DL, Datta PK. Antimetastatic Role of Smad4 Signaling in Colorectal Cancer. Gastroenterology 2009, 138:969-80. e1-3, 10.1053/j.gastro.2009.11.004, 19909744.
38. Yue J, Frey RS, Mulder KM. Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGF-β. Oncogene 1999, 18:2033-2037. 10.1038/sj.onc.1202521, 10208426.
39. Pardali K, Moustakas A. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta 2007, 1775:21-62.
40. Horiguchi K, Shirakihara T, Nakano A, Imamura T, Miyazono K, Saitoh M. Role of Ras signaling in the induction of snail by transforming growth factor-beta. J Biol Chem 2009, 284:245-53. 10.1074/jbc.M804777200, 19010789.
41. Schwarz LC, Gingras MC, Goldberg G, Greenberg AH, Wright JA. Loss of Growth Factor Dependence and Conversion of Transforming Growth Factor-ß1 Inhibition to Stimulation in Metastatic H-ras-transformed Murine Fibroblasts. Cancer Res 1988, 48:6999-7003.
42. Filmus J, Kerbel RS. Development of resistance mechanisms to the growth-inhibitory effects of transforming growth factor-beta during tumor progression. Curr Opin Oncol 1993, 5:123-129.
43. Javelaud D, Mauviel A. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-b: implications for carcinogenesis. Oncogene 2005, 24:5742-5750. 10.1038/sj.onc.1208928, 16123807.
44. Janda E, Lehmann K, Killisch I, et al. Ras and TGF-β cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol 2002, 156:299-313. 10.1083/jcb.200109037, 2199233, 11790801.
45. Miyazono K. Transforming growth factor-b signaling in epithelial-mesenchymal transition and progression of cancer. Proc Jpn Acad Ser B Phys Biol Sci 2009, 85:314-323. 10.2183/pjab.85.314, 19838011.
46. Bardeesy N, Cheng K, Berger JH, et al. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev 2006, 20:3130-3146. 10.1101/gad.1478706, 1635148, 17114584.
47. Izeradjene K, Combs C, Best M, et al. Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas. Cancer Cell 2007, 11:229-43. 10.1016/j.ccr.2007.01.017, 17349581.
48. Al-Mulla F, Going JJ, Sowden ET, Winter A, Pickford IR, Birnie GD. Heterogeneity of mutant versus wild--type in primary and metastatic colorectal carcinomas and association of codon12 valine with early mortality. J Pathol 1998, 185:130-138. 10.1002/(SICI)1096-9896(199806)185:2<130::AID-PATH85>3.0.CO;2-M, 9713338.
49. Schubbert S, Shannon K, Bollag G. Hyperactive Ras in developmental disorders and. Cancer. Nat Rev Cancer 2007, 7:295-308. 10.1038/nrc2109, 17384584.
50. Wang JY, Hsieh JS, Chen FM, et al. High frequency of activated K-ras codon 15 mutant in colorectal carcinomas from Taiwanese patients. Int J Cancer 2003, 107:387-93. 10.1002/ijc.11417, 14506738.
51. Blair A, Zahm SH. Agricultural Exposures and Cancer. Environ Health Perspect 1995, 103(Suppl 8):205-208. 10.2307/3432311, 1518967, 8741784.
52. Ejaz S, Akram W, Lim CW, Lee JJ, Hussain I. Endocrine disrupting pesticides: a leading cause of cancer among rural people in Pakistan. Exp Oncol 2004, 26:98-105.
53. Spiewak R. Pesticides as a cause of occupational skin diseases in farmers. Ann Agric Environ Med 2001, 8:1-5.
54. Lee WJ, Sandler DP, Blair A, Samanic C, Cross AJ, Alavanja MC. Pesticide use and colorectal cancer risk in the Agricultural Health Study. Int J Cancer 2007, 121:339-46. 10.1002/ijc.22635, 17390374.
55. Teitelbaum SL. Questionnaire assessment of nonoccupational pesticide exposure in epidemiologic studies of cancer. J Exp Analy Environ Epidemiol 2002, 12:373-380.